This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignee: Academia Sinica. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: The Innovations of Shang-Te Danny Hsu
Introduction
Shang-Te Danny Hsu is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for viral infections. His work is crucial in addressing health challenges posed by viruses.
Latest Patents
One of his key patents is titled "Recombinant antibody and uses thereof." This patent discloses a recombinant antibody that exhibits binding affinity and neutralizing activity to the porcine epidemic diarrhea virus (PEDV). The invention specifically addresses genotype 1 (G1) and genotype 2b (G2b) PEDV. Additionally, the patent outlines methods for diagnosing and treating PEDV infections using this recombinant antibody.
Career Highlights
Shang-Te Danny Hsu is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at Academia Sinica has positioned him as a leading figure in the field of antibody research. His innovative approaches have garnered attention and respect within the scientific community.
Collaborations
He has collaborated with notable colleagues, including Hui-Wen Chang and Chia-Yu Chang. These collaborations have further enhanced the impact of his research and innovations in the field.
Conclusion
Shang-Te Danny Hsu's contributions to biotechnology, particularly through his patent on recombinant antibodies, highlight his role as an influential inventor. His work not only advances scientific knowledge but also has practical applications in combating viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile